Haplotype analysis in determination of the heredity of erythropoietic protoporphyria among Swiss families

Journal of Investigative Dermatology

Volumn 117, Issue 6, 2001, Pages 1521-1525

  Schneider Yin, Xiaoye ^c   Rüfenacht, Urszula B ^c   Hergersberg, Martin ^a   Schnyder, Cacile ^c   Deybach, Jean Charles ^b   Minder, Elisabeth I ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b HÔPITAL LOUIS MOURIER   (France)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Ferrochelatase; Founder effect; Intragenic SNP; Recurrent mutation

Indexed keywords

FERROCHELATASE; MICROSATELLITE DNA;

ALLELE; ARTICLE; CENTROMERE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPOIETIC PROTOPORPHYRIA; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

EID: 0035678642     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01604.x     Document Type: Article

References (25)

1. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation
2. Comprehensive human genetic maps. Individual and sex-specific variation in recombination
3. A metric map of humans: 23,500 loci in 850 bands
4. Ferrochelatase in human erythropoietic protoporphyria: The first case of a homozygous form of the enzyme deficiency
5. Modulation of the phenotype in dominant erythropoietic protoporphyria by low expression of the normal ferrochelatase gene
6. Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation
7. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate
8. A new mutation, 3905insT, accounts for 4.8% of 1173 CF chromosomes in Switzerland and causes a severe phenotype
9. The porphyrias
10. Analysis of ferrochelatase expression during hematopoietic development of embryonic stem cells
11. Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase
12. The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria
13. Genetic heterogeneity in erythropoietic protoporphyria. A study of the enzymatic defect in nine affected families
14. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria
15. Rapid molecular diagnosis of erythropoietic protoporphyria among Swiss patients
16. Molecular defect in erythropoietic protoporphyria with terminal liver failure
17. Human ferrochelatase: A novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing
18. New insights into the pathogenesis of erythropoietic protoporphyria and their impacts on patient care
19. Identification of a prevalent nonsense mutation (W283X) and two novel mutations in the porphobilinogen deaminase gene of Swiss patients with acute intermittent porphyria
20. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients
21. Structure of the human ferrochelatase gene exon/intron gene organization and location of the gene to chromosome 18
22. Identification of a single base pair deletion (40 del G) in exon 1 of the ferrochelatase gene in patient with erythropoietic protoporphyria
23. Haplotype analysis of families with erythropoietic protoporphyria and novel mutation of the ferrochelatase gene
24. Genetic aspects of erythropoietic protoporphyria
25. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22